| Financial Year |
March 31 2023 |
| Monetary Funds |
1,115,620,852.44 |
| Held-for-trading Financial Assets |
10,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
180,033,751.95 |
| Advances to Suppliers |
11,865,697.88 |
| Other Receivables |
11,127,046.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
83,950,115.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,711,149.80 |
| Total Current Assets |
1,413,318,614.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
441,088.14 |
| Investment Properties |
389,173,708.16 |
| Fixed Assetes |
167,467,837.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,901,949.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,011,550.68 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
2,910,486.00 |
| Sub-Total of Non-Current Assets |
619,677,814.23 |
| Total Assets |
2,032,996,428.26 |
| Short-Term Loans |
579,869,896.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
104,547,082.23 |
| Accounts Received In Advance |
1,089,566.60 |
| Employee Compensation Payable |
10,900,302.29 |
| Taxes Payable |
50,601,619.82 |
| Interest Payable |
-- |
| Dividend Payable |
470,039.98 |
| Other payables |
73,522,348.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,290,471.31 |
| Other Current Liabilities |
145,883.98 |
| Sub-Total of Current Liabilities |
833,427,281.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,621,523.07 |
| Total Liabilities |
853,048,804.15 |
| Paid-In Capital(Or Share Stock) |
672,753,072.00 |
| Capital Surplus |
124,169,926.99 |
| Surplus Reserve |
33,632,834.95 |
| LESS:Treasury Stock |
26,174,600.00 |
| Undistributed Profits |
349,231,655.64 |
| Minority Stockholder's Interest |
30,764,472.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,149,183,151.28 |
| Owner's Equity（Stockholder's Equity） |
1,179,947,624.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,032,996,428.26 |
